← Eichor
Study identifier: NCT06933420 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical Protocol CERN Feasibility Study

Condition: Bacterial Vaginosis · Fungal Vaginal Infections  ·  Sponsor: Cern Corporation

PhaseNA
Planned participants9
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if the intravaginal Cern device works to treat bacterial vaginosis and fungal vaginitis in premenopausal women. It will also learn about the safety of the device. The main questions it aims to answer are: Does the device accomplish symptom resolution and negative diagnostic tests post-treatment? What medical problems do participants have when using the intravaginal device? Participants will use the investigational intravaginal device for 5 consecutive days, participate in teleconferences and weekly follow-ups, attend in-clinic visits, and maintain a study diary.

This description comes directly from the study's public registry record.

Talk to the study team

Gregg Klang  ·  (949) 306-7160  ·  gklang@cerndevice.com

Melanie Santos  ·  (650) 353-6353  ·  melaniesant@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Akerman MedIrvine, California, United StatesRecruiting
Akerman MedOrange, California, United StatesRecruiting
Akerman MedSanta Ana, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06933420